Ludovic Treluyer

Hôpital Cochin Port Royal, UMR 1153, Équipe De Recherche En Épidémiologie Obstétricale, Périnatale Et Pédiatrique
Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

First- and Second-Year Outcomes After Nirsevimab Immunization.

First- and Second-Year Outcomes After Nirsevimab Immunization.

Journal: JAMA pediatrics

Published: August 10, 2026

Dual Immunization Against RSV With RSVpreF and Nirsevimab.

Dual Immunization Against RSV With RSVpreF and Nirsevimab.

Journal: JAMA pediatrics

Published: May 18, 2026

Long-term outcomes of preterm children

Long-term outcomes of preterm children

Journal: La Revue du praticien

Published: March 25, 2026

Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study.

Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: Nationwide Population-Based Effectiveness and Durability Study.

Journal: The Lancet regional health. Europe

Published: March 17, 2026

Respiratory evolution after antenatal betamethasone dose reduction in very preterm neonates: a post hoc analysis of the BETADOSE trial.

Respiratory evolution after antenatal betamethasone dose reduction in very preterm neonates: a post hoc analysis of the BETADOSE trial.

Journal: European journal of pediatrics

Published: March 11, 2026

Evaluation of the safety of doxapram in premature neonates born before 28 weeks of gestation.

Evaluation of the safety of doxapram in premature neonates born before 28 weeks of gestation.

Journal: European journal of pediatrics

Published: December 18, 2024

Early respiratory features of small for gestational age very preterm children.

Early respiratory features of small for gestational age very preterm children.

Journal: European journal of pediatrics

Published: September 19, 2024

Mortality and neurodevelopmental outcomes at 2 years' corrected age of very preterm infants with necrotising enterocolitis or spontaneous intestinal perforation: The EPIPAGE-2 cohort study.

Mortality and neurodevelopmental outcomes at 2 years' corrected age of very preterm infants with necrotising enterocolitis or spontaneous intestinal perforation: The EPIPAGE-2 cohort study.

Journal: European journal of pediatrics

Published: February 26, 2024

Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5-6 years.

Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5-6 years.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: August 03, 2023

Variations in neonatal mortality of preterm infants with intraparenchymal haemorrhage in Europe: the EPICE cohort.

Variations in neonatal mortality of preterm infants with intraparenchymal haemorrhage in Europe: the EPICE cohort.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: July 02, 2023

Neurodevelopment and healthcare utilisation at age 5-6 years in bronchopulmonary dysplasia: an EPIPAGE-2 cohort study.

Neurodevelopment and healthcare utilisation at age 5-6 years in bronchopulmonary dysplasia: an EPIPAGE-2 cohort study.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: January 24, 2023

Intraventricular Hemorrhage in Very Preterm Children: Mortality and Neurodevelopment at Age 5.

Intraventricular Hemorrhage in Very Preterm Children: Mortality and Neurodevelopment at Age 5.

Journal: Pediatrics

Published: December 22, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026